Dose-tailoring of FEC adjuvant chemotherapy based on leukopenia is feasible and well tolerated. Toxicity and dose intensity in the Scandinavian Breast Group phase 3 adjuvant Trial SBG 2000-1

Author： Edlund Per   Ahlgren Johan   Bjerre Karsten   Andersson Michael   Bergh Jonas   Mouridsen Henning   Holmberg Stig B.   Bengtsson Nils-Olof   Jakobsen Erik   Møøller Susanne   Lindman Henrik   Blomqvist Carl  

Publisher： Informa Healthcare

ISSN： 0284-186X

Source： Acta Oncologica, Vol.50, Iss.3, 2011-04, pp. : 329-337

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Racial Disparity in the Dose and Dose Intensity of Breast Cancer Adjuvant Chemotherapy

By Griggs J.J.  

Breast Cancer Research and Treatment, Vol. 81, Iss. 1, 2003-09 ,pp. : 21-31

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF, and weekly docetaxel is feasible and safe in patients with operable breast cancer

By Fountzilas George   Pectasides Dimitrios   Christodoulou Christos   Timotheadou Eleni   Economopoulos Theofanis   Papakostas Pavlos   Papadimitriou Christos   Gogas Helen   Efstratiou Ioannis   Skarlos Dimosthenis  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 479-488

Humana Press, Inc

Access to resources Recommend Favorite

Predictors of reduced dose intensity in patients with early-stage breast cancer receiving adjuvant chemotherapy

By Shayne Michelle   Crawford Jeffrey   Dale David   Culakova Eva   Lyman Gary  

Breast Cancer Research and Treatment, Vol. 100, Iss. 3, 2006-12 ,pp. : 255-262

Springer Publishing Company

Access to resources Recommend Favorite

Neoadjuvant and adjuvant chemotherapy with high-dose ifosfamide, doxorubicin, cisplatin and high-dose methotrexate in non-metastatic osteosarcoma of the extremities: a phase II trial in Japan

By Kudawara Ikuo  

Journal of Chemotherapy, Vol. 25, Iss. 1, 2013-02 ,pp. : 41-48

Maney Publishing

Access to resources Recommend Favorite

Acute and Late Toxicity Following Adjuvant High-Dose Chemotherapy for High-Risk Primary Operable Breast Cancer A Quality Assessment Study

By Svane Inge M.   Homburg Keld M.   Kamby Claus   Nielsen Dorte L.   Roer Ole   Sliffsgaard Dorte   Johnsen Hans E.   Hansen Steen W.  

Acta Oncologica, Vol. 41, Iss. 7-8, 2002-11 ,pp. : 675-683

Informa Healthcare

Access to resources Recommend Favorite